Saakshi Medtech and Panels H1 FY27 Profit Falls 6.1% YoY

Saakshi Medtech and Panels Limited reported a 6.1% year-on-year fall in H1 FY27 net profit to ₹6.2 crore, despite revenue from operations increasing 2.1% to ₹59.5 crore. The results, filed with the NSE on 12 November 2026, point to a slower profit performance than revenue growth during the April-September period.

What did Saakshi Medtech and Panels report for H1 FY27?

Saakshi Medtech and Panels reported total income of ₹59.9 crore for H1 FY27, compared with ₹58.6 crore in H1 FY26. Revenue from operations rose to ₹59.5 crore from ₹58.3 crore, while other income increased to ₹0.4 crore from ₹0.3 crore.

Profit before exceptional items and tax stood at ₹8.3 crore, down from ₹8.8 crore a year earlier. Profit before tax was also ₹8.3 crore. Net profit declined to ₹6.2 crore from ₹6.6 crore in H1 FY26, representing a 6.1% year-on-year decrease.

The company filed its standalone results with the National Stock Exchange at 17:56 IST on 12 November 2026. The filing came 43 days after the end of the half-year on 30 September 2026. The board meeting had been scheduled to consider and approve unaudited financial results for the half year ended September 2026.

How did the latest half year compare with earlier periods?

Saakshi Medtech and Panels delivered higher revenue and profit than in H2 FY26, although its year-on-year profit comparison weakened. Revenue from operations was ₹57.2 crore in H2 FY26 and ₹58.3 crore in H1 FY26, placing the latest ₹59.5 crore performance above both comparison periods.

Net profit improved 8.8% from ₹5.7 crore in H2 FY26 but remained below the ₹6.6 crore reported in H1 FY26. Profit before tax increased from ₹7.8 crore in H2 FY26 but was lower than ₹8.8 crore in the corresponding half of the previous financial year.

What do the margins and growth figures show?

Saakshi Medtech and Panels' operating margin was 13.9% in H1 FY27, improving from 13.6% in H2 FY26 but declining from 15.0% in H1 FY26. This indicates that the company recorded a sequential improvement in margin, while its first-half comparison with the previous year remained weaker.

Revenue growth of 2.1% year on year was modest relative to the decline in profit. The filing showed operating profit down 7.1% from H1 FY26, while operating profit increased 3.9% from H2 FY26. These figures align with the year-on-year reduction in profit before tax and net profit.

For context, the company had reported revenue of ₹57.0 crore and net profit of ₹6.0 crore for the quarter ended March 2026. That period was reported with revenue growth of 18.8% year on year and net-profit growth of 500.0% from a lower base of ₹1.0 crore. The H1 FY27 filing provides a separate half-year comparison and should not be treated as a direct substitute for quarter-specific performance.

Why do the H1 FY27 results matter to investors?

The H1 FY27 results matter because Saakshi Medtech and Panels expanded revenue but did not convert that increase into year-on-year profit growth. Revenue rose by ₹1.2 crore over H1 FY26, whereas net profit fell by ₹0.4 crore and the operating margin contracted by 1.1 percentage points.

For investors, the results provide confirmed standalone financial data after the NSE filing. The reported figures do not include a market-price reaction on the filing date in the supplied information, so no conclusion can be drawn on how the market assessed the announcement. The available data instead show the underlying financial comparison: revenue was higher, while profitability was lower on a year-on-year basis.

Saakshi Medtech and Panels operates in electrical equipment and also has a medical-device division. The supplied company information states that the division holds a commercial production licence from the Atomic Energy Regulatory Board and a licence from the Central Drugs Standard Control Organization to manufacture medical devices for testing purposes. These regulatory permissions are part of the company background, although the H1 FY27 filing does not quantify their contribution to revenue or profit.

Conclusion

Saakshi Medtech and Panels closed H1 FY27 with ₹59.5 crore in revenue from operations and ₹6.2 crore in net profit. The results show sequential improvement over H2 FY26 in revenue, profit and operating margin, but year-on-year profit and margin remained below H1 FY26 levels despite modest revenue growth.

The next reported financial update will be important for assessing whether revenue growth strengthens and whether the gap between sales growth and profit growth narrows. Investors can also track subsequent NSE filings for the company's financial results and disclosures related to its operations.